Pyxis Oncology, Inc. (PYXS)
1.64
-0.05
(-2.96%)
USD |
NASDAQ |
Nov 03, 15:14
Pyxis Oncology EPS Diluted (Quarterly) : -0.3961 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3961 |
| March 31, 2026 | -0.3667 |
| December 31, 2025 | -0.2888 |
| September 30, 2025 | -0.3517 |
| June 30, 2025 | -0.2964 |
| March 31, 2025 | -0.3466 |
| December 31, 2024 | -0.597 |
| September 30, 2024 | -0.3492 |
| June 30, 2024 | -0.286 |
| March 31, 2024 | -0.0635 |
| December 31, 2023 | -0.3485 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.5577 |
| June 30, 2023 | -0.4142 |
| March 31, 2023 | -0.5443 |
| December 31, 2022 | -1.033 |
| September 30, 2022 | -0.8499 |
| June 30, 2022 | -0.7877 |
| March 31, 2022 | -0.9693 |
| December 31, 2021 | -0.5223 |
| September 30, 2021 | -0.4132 |
| December 31, 2020 | -0.1335 |
| September 30, 2020 | -0.093 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | 0.1812 |
| Cue Biopharma, Inc. | -24.14 |
| Yarrow Bioscience, Inc. | -3.504 |
| Faeth Therapeutics, Inc. | -2.836 |
| Indaptus Therapeutics, Inc. | -0.0155 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.35M |
| Total Expenses (Quarterly) | 25.35M |
| Enterprise Value | 90.57M |
| Earnings Yield | -85.57% |
| Normalized Earnings Yield | -85.57 |